
Once-monthly subcutaneous olanzapine TEV-749 shows sustained stabilization and remission in schizophrenia, supports direct switching, and avoids post-injection monitoring.
Poetry of the Times
My foot slaps time and I nod
"yes, yes, yes" as the trio
brings Beethoven's melody
back to life, violin, cello,
clarinet coming in to comment
like small talk at the pre-concert party.
There were stories of tornadoes,
rain, someone's near-miss car crash.
And the moment a woman scraped
one long, sour note when she asked
my friend if her son has schizophrenia,
the reply reeled off like a soloist
who knows how to play through
mistakes without missing a beat.
about 19 years ago
The Brain That Changes Itselfabout 19 years ago
The Human Heart of Psychiatryover 19 years ago
Postpartum Depression Bill Likely to Move Forwardover 19 years ago
Clinical Manual of Geriatric Psychopharmacologyover 19 years ago
Violence Against Mental Health Professionals: A Reader Respondsover 19 years ago
Medication Discontinuation Difficult in First-Episode Schizophreniaover 19 years ago
Mental Illness on the Screenover 19 years ago
Faith in Psychiatryover 19 years ago
Compulsive Gamingover 19 years ago
Shelter-Based Collaborative Mental Health Care for the Homeless





